Timeline
MBP134
Experimental cross-species Ebola antibody cocktail; first authorised therapeutic intervention in the 2026 outbreak.
9 of 9 entries (9 events, 0 interactions)
Filters
#12 31 Jul
Mentioned in: CEPI puts a Bundibugyo vaccine in trials
Pandemics and Biosecurity#11 16 Jul
Africa CDC: true cases up to 4x tally
Pandemics and Biosecurity#9 2 Jul
Formed one of four randomised treatment arms alongside remdesivir
Pandemics and Biosecurity: Ebola trial doses its first patient#8 17 Jun
Mentioned in: Africa CDC wins direct pandemic funding
Pandemics and Biosecurity#7 12 Jun
Entered first authorised clinical trial as two-antibody treatment arm for Bundibugyo Ebola
Pandemics and Biosecurity: First Ebola treatment trial goes live#5 1 Jun
Remained unauthorised to dose any patient as of 29 May
Pandemics and Biosecurity: Only Ebola treatment still cannot dose#6 1 Jun
$112m for vaccines, none for the wards
Pandemics and Biosecurity#4 20 May
Demonstrated 100% animal protection up to eight days post-infection and awaited regulatory clearance for human trial
Pandemics and Biosecurity: Ebola drug trial awaits DRC, Uganda nod#4 20 May